Association Between Onset Age of Coronary Heart Disease and Incident Dementia: A Prospective Cohort Study

Jie Liang1, Chenglong Li2,3, Darui Gao2,3

  • 1Department of Clinical Nursing, School of Nursing Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China.

Insights

Younger onset of coronary heart disease (CHD) increases dementia risk. Early CHD diagnosis necessitates monitoring neurocognitive health to prevent future dementia.

Area of Science:

  • Cardiology
  • Neurology
  • Epidemiology

Background:

  • The link between age of coronary heart disease (CHD) onset and subsequent dementia risk is not well understood.
  • Coronary heart disease (CHD) is a significant risk factor for cardiovascular and cerebrovascular diseases.
  • Dementia encompasses a range of progressive neurological disorders impacting memory and cognitive function.

Purpose of the Study:

  • To investigate the association between the age of coronary heart disease (CHD) onset and the risk of developing incident dementia.
  • To determine if earlier onset of CHD correlates with a higher likelihood of dementia.
  • To analyze the impact of CHD on all-cause dementia, Alzheimer's disease, and vascular dementia.

Main Methods:

  • Utilized data from the UK Biobank, including baseline and follow-up diagnostic information for CHD and dementia.
  • Employed propensity score matching and Cox proportional hazards models to assess the relationship between CHD onset age and dementia risk.
  • Included 432,667 adults, with 11.7% diagnosed with CHD, analyzing dementia incidence across different CHD onset ages.

Main Results:

  • Participants with CHD showed significantly higher risks for all-cause dementia, Alzheimer's disease, and vascular dementia compared to those without CHD.
  • A younger age at CHD onset was independently associated with substantially increased risks of all-cause dementia, Alzheimer's disease, and vascular dementia.
  • Risk for dementia escalated with decreasing age of CHD onset, even after propensity score matching.

Conclusions:

  • Earlier onset of coronary heart disease (CHD) is a significant predictor of increased risk for all-cause dementia, Alzheimer's disease, and vascular dementia.
  • Individuals diagnosed with CHD at a younger age require vigilant monitoring of their neurocognitive status.
  • Timely interventions targeting younger CHD patients may help mitigate the subsequent risk of developing dementia.
Abstract

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
115
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
494
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
558
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
119